We extend our sincere gratitude to all sponsors for their generous support and contribution to the success of the Indonesian Biopharmaceutical Summit (IBS) 2025. Their partnership and support play a vital role in making this event possible and in advancing collaboration and innovation within Indonesia’s biopharmaceutical sector.
Below are our esteemed sponsors for IBS 2025:
AUSTAR is dedicated to serving the life sciences with leading technology, possessing comprehensive knowledge and experience in process technology, applications, regulatory rules, and practices in the life sciences. We take pride in helping clients address issues in quality, compliance, and operational excellence, and are dedicated to providing turnkey solutions in equipment, engineering, service, and consumables, so as to promote industry progress and create value.
With a full spectrum of life sciences technology knowledge, AUSTAR has leading technical application capabilities and high-quality equipment and systems in the area of Clean Utilities, Automation and Digitalization, Formulation Technology, Biopharma Process and Technology, Regulatory Compliance and Operation Excellence, Laboratory Technology and Facilities, Biosafety Technology and Facilities, Cleaning, Sterilization and Disinfection, Clean Room/HVAC/EMS/BMS, Quality/Measurement and Analytics, Filling, Freeze-Drying and Inspection, Containment Technology.
AUSTAR Group was founded in 1991 in Hong Kong, the Company was listed on the Main Board of the Stock Exchange of Hong Kong Limited on 7 November, 2014 (Stock code: 06118).
Cytiva is part of Danaher, a global science and technology leader. Along with Danaher’s diagnostic and life sciences businesses, we bring an innovative mindset to our collaborations with customers to help them improve patient outcomes.
Cytiva envisions a world in which access to life-changing therapies transforms human health. With a rich heritage dating back hundreds of years, our wealth of technical expertise and talent, a broad and deep portfolio, and exceptional service help researchers and biopharma advance therapeutics at every stage from discovery to delivery.
LePure Biotech was founded in 2011, specializes in single-use systems and consumables for the biopharmaceutical industry. We offer reliable and high-quality bioprocessing solutions with vertically integrated manufacturing from in-house film extrusion to final product assembly, ensuring quality, consistency, and control.
With R&D and commercial operations across the U.S., South China, and Korea, our global footprint enables faster lead times and greater responsiveness, keeping your projects on track in today’s fast-paced market.
Our production process enables us to optimize costs without compromising on the quality of our single-use equipment and consumables. LePure Biotech remains dedicated to delivering cost-effective solutions without compromising the cutting-edge technology and reliability that we are renowned for.
Merck’s passion for science and technology drives approximately 62,000 employees in 65 countries to address some of today’s toughest challenges and develop more sustainable ways of living.
In our rapidly changing and uncertain world, factors such as an aging population, chronic diseases, AI, climate change, and other megatrends have created an appetite for scientific breakthroughs that can make a positive difference across our global society. The pace of change will increase over coming decades as technologies evolve and converge in ways that fundamentally transform how we live and work. For us at Merck, change is not a threat but an opportunity as we have proven for over more than 350 years.
Sparking Discovery, Elevating Humanity as our unifying vision
Together we are guided by strong family values and a clear ethical compass. We prioritize the needs of current and future generations. With our multi-industry business model, diverse team, and global presence, we possess a unique competitive advantage.
Together as one team Merck, we are dedicated to Sparking Discovery, Elevating Humanity for a brighter, more sustainable future! This is our promise to millions of customers, patients, and communities worldwide.
Morimatsu Pharmadule is the founder of modular delivery concept for pharmaceutical facilities. Morimatsu has successfully delivered integrated upstream and downstream projects to produce insulin, monoclonal antibodies, vaccines, recombinant albumin, recombinant factor, ADC (antibody-drug conjugates), polypeptides, etc. to many well-known biopharmaceutical manufacturers.
From the start in Japan, Morimatsu has grown and today is a diversified multinational corporation with vast experience and professional know-how in fields of process engineering equipment as well as modular engineering solutions. Our company has established long-term collaboration relationships with numerous well-known global corporations. We have companies in Sweden, Switzerland, Italy, US, India, Singapore, together with the large scale operation and manufacturing facilities in Asia. So far, Morimatsu has delivered projects to more than 40 countries/regions in the world, established an excellent industrial reputation in the process.
Morimatsu is dedicated in providing core equipment, process systems, integrated engineering solutions, modular plants, and digital operations for life sciences, fast-moving consumer goods, and aesthetics industries. Our highly skilled professional teams, which include project managers, design engineers, validation experts, and operational technicians, continuously bringing clients the most advanced industrial concepts as well as cutting-edge technologies.
As a leading partner of the biopharmaceutical industry, Sartorius Stedim Biotech helps its customers to develop their production processes and manufacture biotech medications and vaccines more efficiently. Sartorius Stedim Biotech is a globally operating company with subsidiaries in more than 30 countries and around 9,900 employees worldwide.
The parent company of the Sartorius Stedim Biotech Group is Sartorius Stedim Biotech S.A., headquartered in Aubagne, France and listed on the Euronext stock exchange in Paris. Approximately 72% of the share capital and around 83% of the voting rights of Sartorius Stedim Biotech S.A. are held by Sartorius AG.
Syntegon is a leading global technology company and strategic partner to the pharmaceutical, biotech, and food industries.
With a strategic focus on the growing pharmaceutical and biotech sectors, we play a vital role in global healthcare, providing in-depth process expertise and mission-critical technologies for the safe, efficient, and compliant production of essential medicines.
In the food sector, we are recognized for our high-speed, high-precision packaging solutions, drawing on unique engineering excellence to help food manufacturers improve performance and product quality
Founded in 2000, Truking Technology Limited has become one of the major pharmaceutical equipment suppliers in the world. The company specializes in pharmaceutical equipment and the corresponding integrated solutions, and takes the initiative to push forward the R&D of smart pharmaceutical factory.
It is a listed A-share company with multiple wholly-owned or controlling subsidiaries, namely the Germany-based Romaco Group, Truking Watertown, Sichuan Pharmaceutical Degisn Institute, Truking Feiyun, Truking Ingenuity Biotechnology, Truking Wachine, Truking Intelligent Robot, Truking Micno, Truking Gene, Truking SUT, Truking Changxin, Truking Scientific Instrument and Truking Pitide, etc.
Truking has established National Enterprise Technology Center, National Innovation Center, Post-Doctoral Research Center, Academician Expert Workstation and many more technology and innovation platforms.
To better respond to the needs of global customers, Truking has been setting up sales and service centers in many countries including India, Italy, Greece, Russia, Uzbekistan, Turkey, Egypt, Bangladesh, Korea, Vietnam and Thailand, etc.